Hepatitis B Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Vaccine (Recombinant) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Vaccine (Recombinant) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Vaccine (Recombinant) Overall Market Size
2.1 Global Hepatitis B Vaccine (Recombinant) Market Size: 2022 VS 2030
2.2 Global Hepatitis B Vaccine (Recombinant) Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Hepatitis B Vaccine (Recombinant) Sales: 2018-2030
3 Company Landscape
3.1 Top Hepatitis B Vaccine (Recombinant) Players in Global Market
3.2 Top Global Hepatitis B Vaccine (Recombinant) Companies Ranked by Revenue
3.3 Global Hepatitis B Vaccine (Recombinant) Revenue by Companies
3.4 Global Hepatitis B Vaccine (Recombinant) Sales by Companies
3.5 Global Hepatitis B Vaccine (Recombinant) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis B Vaccine (Recombinant) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis B Vaccine (Recombinant) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis B Vaccine (Recombinant) Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis B Vaccine (Recombinant) Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis B Vaccine (Recombinant) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis B Vaccine (Recombinant) Market Size Markets, 2022 & 2030
4.1.2 10mcg/0.5ml
4.1.3 10mcg/ml
4.2 By Type - Global Hepatitis B Vaccine (Recombinant) Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Vaccine (Recombinant) Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis B Vaccine (Recombinant) Revenue, 2024-2030
4.2.3 By Type - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
4.3 By Type - Global Hepatitis B Vaccine (Recombinant) Sales & Forecasts
4.3.1 By Type - Global Hepatitis B Vaccine (Recombinant) Sales, 2018-2023
4.3.2 By Type - Global Hepatitis B Vaccine (Recombinant) Sales, 2024-2030
4.3.3 By Type - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
4.4 By Type - Global Hepatitis B Vaccine (Recombinant) Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Vaccine (Recombinant) Market Size, 2022 & 2030
5.1.2 Newborn
5.1.3 Adult
5.2 By Application - Global Hepatitis B Vaccine (Recombinant) Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Vaccine (Recombinant) Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis B Vaccine (Recombinant) Revenue, 2024-2030
5.2.3 By Application - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
5.3 By Application - Global Hepatitis B Vaccine (Recombinant) Sales & Forecasts
5.3.1 By Application - Global Hepatitis B Vaccine (Recombinant) Sales, 2018-2023
5.3.2 By Application - Global Hepatitis B Vaccine (Recombinant) Sales, 2024-2030
5.3.3 By Application - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
5.4 By Application - Global Hepatitis B Vaccine (Recombinant) Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Hepatitis B Vaccine (Recombinant) Market Size, 2022 & 2030
6.2 By Region - Global Hepatitis B Vaccine (Recombinant) Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Vaccine (Recombinant) Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis B Vaccine (Recombinant) Revenue, 2024-2030
6.2.3 By Region - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
6.3 By Region - Global Hepatitis B Vaccine (Recombinant) Sales & Forecasts
6.3.1 By Region - Global Hepatitis B Vaccine (Recombinant) Sales, 2018-2023
6.3.2 By Region - Global Hepatitis B Vaccine (Recombinant) Sales, 2024-2030
6.3.3 By Region - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Hepatitis B Vaccine (Recombinant) Revenue, 2018-2030
6.4.2 By Country - North America Hepatitis B Vaccine (Recombinant) Sales, 2018-2030
6.4.3 US Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.4.4 Canada Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.4.5 Mexico Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Hepatitis B Vaccine (Recombinant) Revenue, 2018-2030
6.5.2 By Country - Europe Hepatitis B Vaccine (Recombinant) Sales, 2018-2030
6.5.3 Germany Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.5.4 France Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.5.5 U.K. Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.5.6 Italy Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.5.7 Russia Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.5.8 Nordic Countries Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.5.9 Benelux Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Hepatitis B Vaccine (Recombinant) Revenue, 2018-2030
6.6.2 By Region - Asia Hepatitis B Vaccine (Recombinant) Sales, 2018-2030
6.6.3 China Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.6.4 Japan Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.6.5 South Korea Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.6.6 Southeast Asia Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.6.7 India Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Hepatitis B Vaccine (Recombinant) Revenue, 2018-2030
6.7.2 By Country - South America Hepatitis B Vaccine (Recombinant) Sales, 2018-2030
6.7.3 Brazil Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.7.4 Argentina Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales, 2018-2030
6.8.3 Turkey Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.8.4 Israel Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.8.5 Saudi Arabia Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
6.8.6 UAE Hepatitis B Vaccine (Recombinant) Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis B Vaccine (Recombinant) Major Product Offerings
7.1.4 GSK Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis B Vaccine (Recombinant) Major Product Offerings
7.2.4 Merck Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Company Summary
7.3.2 Sanofi Pasteur Business Overview
7.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Major Product Offerings
7.3.4 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Pasteur Key News & Latest Developments
7.4 Dynavax Technologies
7.4.1 Dynavax Technologies Company Summary
7.4.2 Dynavax Technologies Business Overview
7.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Major Product Offerings
7.4.4 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2018-2023)
7.4.5 Dynavax Technologies Key News & Latest Developments
7.5 LG Life Sciences
7.5.1 LG Life Sciences Company Summary
7.5.2 LG Life Sciences Business Overview
7.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Major Product Offerings
7.5.4 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2018-2023)
7.5.5 LG Life Sciences Key News & Latest Developments
7.6 KM Biologics
7.6.1 KM Biologics Company Summary
7.6.2 KM Biologics Business Overview
7.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Major Product Offerings
7.6.4 KM Biologics Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2018-2023)
7.6.5 KM Biologics Key News & Latest Developments
7.7 Shenzhen Kangtai Biological Products
7.7.1 Shenzhen Kangtai Biological Products Company Summary
7.7.2 Shenzhen Kangtai Biological Products Business Overview
7.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Major Product Offerings
7.7.4 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2018-2023)
7.7.5 Shenzhen Kangtai Biological Products Key News & Latest Developments
7.8 Serum Institute
7.8.1 Serum Institute Company Summary
7.8.2 Serum Institute Business Overview
7.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Major Product Offerings
7.8.4 Serum Institute Hepatitis B Vaccine (Recombinant) Sales and Revenue in Global (2018-2023)
7.8.5 Serum Institute Key News & Latest Developments
8 Global Hepatitis B Vaccine (Recombinant) Production Capacity, Analysis
8.1 Global Hepatitis B Vaccine (Recombinant) Production Capacity, 2018-2030
8.2 Hepatitis B Vaccine (Recombinant) Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis B Vaccine (Recombinant) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis B Vaccine (Recombinant) Supply Chain Analysis
10.1 Hepatitis B Vaccine (Recombinant) Industry Value Chain
10.2 Hepatitis B Vaccine (Recombinant) Upstream Market
10.3 Hepatitis B Vaccine (Recombinant) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis B Vaccine (Recombinant) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Hepatitis B Vaccine (Recombinant) in Global Market
Table 2. Top Hepatitis B Vaccine (Recombinant) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatitis B Vaccine (Recombinant) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Companies, 2018-2023
Table 5. Global Hepatitis B Vaccine (Recombinant) Sales by Companies, (K Units), 2018-2023
Table 6. Global Hepatitis B Vaccine (Recombinant) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatitis B Vaccine (Recombinant) Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Hepatitis B Vaccine (Recombinant) Product Type
Table 9. List of Global Tier 1 Hepatitis B Vaccine (Recombinant) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Vaccine (Recombinant) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2018-2023
Table 15. By Type - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2024-2030
Table 16. By Application ? Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2018-2023
Table 20. By Application - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2024-2030
Table 21. By Region ? Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatitis B Vaccine (Recombinant) Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2018-2023
Table 25. By Region - Global Hepatitis B Vaccine (Recombinant) Sales (K Units), 2024-2030
Table 26. By Country - North America Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2018-2023
Table 29. By Country - North America Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2024-2030
Table 30. By Country - Europe Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2018-2023
Table 33. By Country - Europe Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2024-2030
Table 34. By Region - Asia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2018-2023
Table 37. By Region - Asia Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2024-2030
Table 38. By Country - South America Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2018-2023
Table 41. By Country - South America Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales, (K Units), 2024-2030
Table 46. GSK Company Summary
Table 47. GSK Hepatitis B Vaccine (Recombinant) Product Offerings
Table 48. GSK Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Hepatitis B Vaccine (Recombinant) Product Offerings
Table 52. Merck Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Sanofi Pasteur Company Summary
Table 55. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Offerings
Table 56. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Pasteur Key News & Latest Developments
Table 58. Dynavax Technologies Company Summary
Table 59. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Offerings
Table 60. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Dynavax Technologies Key News & Latest Developments
Table 62. LG Life Sciences Company Summary
Table 63. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Offerings
Table 64. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. LG Life Sciences Key News & Latest Developments
Table 66. KM Biologics Company Summary
Table 67. KM Biologics Hepatitis B Vaccine (Recombinant) Product Offerings
Table 68. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. KM Biologics Key News & Latest Developments
Table 70. Shenzhen Kangtai Biological Products Company Summary
Table 71. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Offerings
Table 72. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Shenzhen Kangtai Biological Products Key News & Latest Developments
Table 74. Serum Institute Company Summary
Table 75. Serum Institute Hepatitis B Vaccine (Recombinant) Product Offerings
Table 76. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Serum Institute Key News & Latest Developments
Table 78. Hepatitis B Vaccine (Recombinant) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Hepatitis B Vaccine (Recombinant) Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Hepatitis B Vaccine (Recombinant) Production by Region, 2018-2023 (K Units)
Table 81. Global Hepatitis B Vaccine (Recombinant) Production by Region, 2024-2030 (K Units)
Table 82. Hepatitis B Vaccine (Recombinant) Market Opportunities & Trends in Global Market
Table 83. Hepatitis B Vaccine (Recombinant) Market Drivers in Global Market
Table 84. Hepatitis B Vaccine (Recombinant) Market Restraints in Global Market
Table 85. Hepatitis B Vaccine (Recombinant) Raw Materials
Table 86. Hepatitis B Vaccine (Recombinant) Raw Materials Suppliers in Global Market
Table 87. Typical Hepatitis B Vaccine (Recombinant) Downstream
Table 88. Hepatitis B Vaccine (Recombinant) Downstream Clients in Global Market
Table 89. Hepatitis B Vaccine (Recombinant) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis B Vaccine (Recombinant) Segment by Type in 2022
Figure 2. Hepatitis B Vaccine (Recombinant) Segment by Application in 2022
Figure 3. Global Hepatitis B Vaccine (Recombinant) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Vaccine (Recombinant) Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hepatitis B Vaccine (Recombinant) Revenue, 2018-2030 (US$, Mn)
Figure 7. Hepatitis B Vaccine (Recombinant) Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis B Vaccine (Recombinant) Revenue in 2022
Figure 9. By Type - Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
Figure 11. By Type - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
Figure 12. By Type - Global Hepatitis B Vaccine (Recombinant) Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
Figure 15. By Application - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
Figure 16. By Application - Global Hepatitis B Vaccine (Recombinant) Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
Figure 20. By Region - Global Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
Figure 21. By Country - North America Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
Figure 22. By Country - North America Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
Figure 23. US Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
Figure 28. Germany Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 29. France Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
Figure 37. China Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 41. India Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
Figure 43. By Country - South America Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
Figure 44. Brazil Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share, 2018-2030
Figure 48. Turkey Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Hepatitis B Vaccine (Recombinant) Revenue, (US$, Mn), 2018-2030
Figure 52. Global Hepatitis B Vaccine (Recombinant) Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Hepatitis B Vaccine (Recombinant) by Region, 2022 VS 2030
Figure 54. Hepatitis B Vaccine (Recombinant) Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
